Drugs / Ad4-PA-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01979406 | Nov 2013 → Oct 2014 | anthrax infection | Emergent BioSolutions | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad4-PA-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01979406 ↗ |
| Route | Oral | “three different dose of oral dosages of Ad4-PA (protective antigen) and Ad4-PA-GPI” NCT01979406 ↗ |